D. Quaresmini
发表
M. C. Comes,
R. Massafra,
A. Zito,
2022,
Cancers.
F. Silvestris,
M. Cives,
M. Tucci,
2019,
Neuroendocrinology.
B. Mandriani,
F. Silvestris,
M. Cives,
2019,
Current Treatment Options in Oncology.
R. Massafra,
M. Guida,
A. Fanizzi,
2021,
Cells.
R. Palmirotta,
E. Silvestris,
D. Lovero,
2018,
International journal of molecular sciences.
G. Brandi,
A. Scarpa,
C. Luchini,
2022,
Critical reviews in oncology/hematology.
M. Guida,
D. Quaresmini,
2020,
Frontiers in Immunology.
R. Massafra,
M. Guida,
S. Tommasi,
2021,
Frontiers in Oncology.
M. Caria,
D. Quaresmini,
G. Minini,
2010
.
Raffaele Palmirotta,
R. Palmirotta,
D. Lovero,
2018,
Therapeutic advances in medical oncology.
Andrew J. Park,
A. Hauschild,
J. Malvehy,
2016,
Journal of Translational Medicine.
F. Dammacco,
R. Palmirotta,
D. Lovero,
2019,
Oncogenomics.
R. Palmirotta,
D. Lovero,
F. Silvestris,
2017,
Pharmacogenomics.
N. Bartolomeo,
G. Madonna,
P. Ascierto,
2022,
Journal of translational medicine.
N. Bartolomeo,
G. Madonna,
P. Ascierto,
2021,
Cancers.
C. Carella,
R. Palmirotta,
E. Silvestris,
2017,
The International journal of biological markers.
R. Palmirotta,
E. Silvestris,
D. Lovero,
2017,
Cancer genomics & proteomics.
F. Silvestris,
M. Cives,
S. D’Oronzo,
2017,
Oncotarget.
M. Guida,
R. Buquicchio,
R. Filotico,
2021,
Frontiers in Oncology.
Andrew J. Park,
Ludmila V. Danilova,
David C. Smith,
2016,
Journal of Translational Medicine.
M. Guida,
D. Quaresmini,
2022,
Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy.
M. Falconi,
G. Zamboni,
S. Partelli,
2019,
Scientific Reports.
F. Silvestris,
M. Cives,
S. D’Oronzo,
2017,
Oncotarget.